One of the largest pharmaceutical manufacturers needed to understand treatment of platinum-resistant ovarian cancer patients — stage and line breakdowns, how treatment choice is actually determined, the challenges and prognosis, and how response is monitored.
Through Growth+Connect, our expert engagement service, we connected the client with 24 US oncologists and gynecologic oncologists for one-hour, one-on-one discussions — including division leadership at major academic cancer centers and physicians with decades of practice at leading institutions.
Recruitment to final English transcripts: five and a half weeks. Every expert verified, every identity protected — the client received depth, not names.
When the question needs the people who wrote the guidelines, Growth+Connect is how you reach them. Talk to our team.